Microbial infection, inflammation and epithelial ovarian cancer (Review)
- Authors:
- Xiaohui Xie
- Mengyuan Yang
- Yiling Ding
- Jianlin Chen
-
Affiliations: Department of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410001, P.R. China - Published online on: June 15, 2017 https://doi.org/10.3892/ol.2017.6388
- Pages: 1911-1919
-
Copyright: © Xie et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Herzog TJ and Pothuri B: Ovarian cancer: A focus on management of recurrent disease. Nat Clin Pract Oncol. 3:604–611. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Hunn J and Rodriguez GC: Ovarian cancer: Etiology, risk factors, and epidemiology. Clin Obstet Gynecol. 55:3–23. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lin HW, Tu YY, Lin SY, Su WJ, Lin WL, Lin WZ, Wu SC and Lai YL: Risk of ovarian cancer in women with pelvic inflammatory disease: A population-based study. Lancet Oncol. 12:900–904. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Risch HA and Howe GR: Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 4:447–451. 1995.PubMed/NCBI | |
|
Shu XO, Brinton LA, Gao YT and Yuan JM: Population-based case-control study of ovarian cancer in Shanghai. Cancer Res. 49:3670–3674. 1989.PubMed/NCBI | |
|
Kuper H, Adami HO and Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med. 248:171–183. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Garrett WS: Cancer and the microbiota. Science. 348:80–86. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Centers for Disease Control and Prevention1, ; Workowski KA and Berman SM: Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 55:1–94. 2006. | |
|
Ladany S and Sarov I: Recent advances in chlamydia trachomatis. Eur J Epidemiol. 1:235–256. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Moulder JW: Interaction of chlamydiae and host cells in vitro. Microbiol Rev. 55:143–190. 1991.PubMed/NCBI | |
|
Molano M, Meijer CJ, Weiderpass E, Arslan A, Posso H, Franceschi S, Ronderos M, Muñoz N and van den Brule AJ: The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: A 5-year follow-up study. J Infect Dis. 191:907–916. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Tosi MF: Innate immune responses to infection. J Allergy Clin Immunol. 116:241–249; quiz 250. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
den Hartog JE, Morré SA and Land JA: Chlamydia trachomatis-associated tubal factor subfertility: Immunogenetic aspects and serological screening. Hum Reprod Update. 12:719–730. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Sellami H, Said-Sadier N, Znazen A, Gdoura R, Ojcius DM and Hammami A: Chlamydia trachomatis infection increases the expression of inflammatory tumorigenic cytokines and chemokines as well as components of the Toll-like receptor and NF-κB pathways in human prostate epithelial cells. Mol Cell Probes. 28:147–154. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
King AE, Wheelhouse N, Cameron S, McDonald SE, Lee KF, Entrican G, Critchley HO and Horne AW: Expression of secretory leukocyte protease inhibitor and elafin in human fallopian tube and in an in-vitro model of Chlamydia trachomatis infection. Hum Reprod. 24:679–686. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Derbigny WA, Shobe LR, Kamran JC, Toomey KS and Ofner S: Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells. Infect Immun. 80:254–265. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Frazer LC, Darville T, Chandra-Kuntal K, Andrews CW Jr, Zurenski M, Mintus M, AbdelRahman YM, Belland RJ, Ingalls RR and O'Connell CM: Plasmid-cured Chlamydia caviae activates TLR2-dependent signaling and retains virulence in the guinea pig model of genital tract infection. PLoS One. 7:e307472012. View Article : Google Scholar : PubMed/NCBI | |
|
Mascellino MT, Boccia P and Oliva A: Immunopathogenesis in Chlamydia trachomatis infected women. ISRN Obstet Gynecol. 2011:4369362011. View Article : Google Scholar : PubMed/NCBI | |
|
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 90:1–636. 2007.PubMed/NCBI | |
|
Shanmughapriya S, Senthilkumar G, Vinodhini K, Das BC, Vasanthi N and Natarajaseenivasan K: Viral and bacterial aetiologies of epithelial ovarian cancer. Eur J Clin Microbiol Infect Dis. 31:2311–2317. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Idahl A, Lundin E, Jurstrand M, Kumlin U, Elgh F, Ohlson N and Ottander U: Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors. Infect Dis Obstet Gynecol. 2011:8246272011. View Article : Google Scholar : PubMed/NCBI | |
|
Carvalho JP and Carvalho FM: Is Chlamydia-infected tubal fimbria the origin of ovarian cancer? Med Hypotheses. 71:690–693. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kessler M, Zielecki J, Thieck O, Mollenkopf HJ, Fotopoulou C and Meyer TF: Chlamydia trachomatis disturbs epithelial tissue homeostasis in fallopian tubes via paracrine Wnt signaling. Am J Pathol. 180:186–198. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zügel U and Kaufmann SH: Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev. 12:19–39. 1999.PubMed/NCBI | |
|
Pockley AG: Heat shock proteins as regulators of the immune response. Lancet. 362:469–276. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Di Felice V, David S, Cappello F, Farina F and Zummo G: Is chlamydial heat shock protein 60 a risk factor for oncogenesis? Cell Mol Life Sci. 62:4–9. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Tsai YP, Yang MH, Huang CH, Chang SY, Chen PM, Liu CJ, Teng SC and Wu KJ: Interaction between HSP60 and beta-catenin promotes metastasis. Carcinogenesis. 30:1049–1057. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Giaginis C, Daskalopoulou SS, Vgenopoulou S, Sfiniadakis I, Kouraklis G and Theocharis SE: Heat Shock Protein-27, −60 and −90 expression in gastric cancer: Association with clinicopathological variables and patient survival. BMC Gastroenterol. 9:142009. View Article : Google Scholar : PubMed/NCBI | |
|
Bodzek P, Partyka R and Damasiewicz-Bodzek A: Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer. J Ovarian Res. 7:302014. View Article : Google Scholar : PubMed/NCBI | |
|
Lim R, Lappas M, Ahmed N, Permezel M, Quinn MA and Rice GE: 2D-PAGE of ovarian cancer: Analysis of soluble and insoluble fractions using medium-range immobilized pH gradients. Biochem Biophys Res Commun. 406:408–413. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tully JG, Taylor-Robinson D, Cole RM and Rose DL: A newly discovered mycoplasma in the human urogenital tract. Lancet. 1:1288–1291. 1981. View Article : Google Scholar : PubMed/NCBI | |
|
Gibson DG, Benders GA, Andrews-Pfannkoch C, Denisova EA, Baden-Tillson H, Zaveri J, Stockwell TB, Brownley A, Thomas DW, Algire MA, et al: Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science. 319:1215–1220. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Fraser CM, Gocayne JD, White O, Adams MD, Clayton RA, Fleischmann RD, Bult CJ, Kerlavage AR, Sutton G, Kelley JM, et al: The minimal gene complement of Mycoplasma genitalium. Science. 270:397–403. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Manhart LE, Holmes KK, Hughes JP, Houston LS and Totten PA: Mycoplasma genitalium among young adults in the United States: An emerging sexually transmitted infection. Am J Public Health. 97:1118–1125. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Taylor-Robinson D and Jensen JS: Mycoplasma genitalium: From Chrysalis to multicolored butterfly. Clin Microbiol Rev. 24:498–514. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Idahl A, Lundin E, Elgh F, Jurstrand M, Møller JK, Marklund I, Lindgren P and Ottander U: Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obstet Gynecol. 202:71.e1–e6. 2010. View Article : Google Scholar | |
|
Chan PJ, Seraj IM, Kalugdan TH and King A: Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA. Gynecol Oncol. 63:258–260. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Quirk JT, Kupinski JM and DiCioccio RA: Detection of mycoplasma ribosomal DNA sequences in ovarian tumors by nested PCR. Gynecol Oncol. 83:560–562. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, Reyes L, Sakamoto N and Rosser CJ: Persistent exposure to mycoplasma induces malignant transformation of human prostate cells. PLoS One. 4:e68722009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Wear DJ and Lo S: Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells. FEMS Immunol Med Microbiol. 27:43–50. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
McGowin CL, Popov VL and Pyles RB: Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. BMC Microbiol. 9:1392009. View Article : Google Scholar : PubMed/NCBI | |
|
Tsai S, Wear DJ, Shih JW and Lo SC: Mycoplasmas and oncogenesis: Persistent infection and multistage malignant transformation. Proc Natl Acad Sci USA. 92:pp. 10197–10201. 1995; View Article : Google Scholar : PubMed/NCBI | |
|
Haggerty CL and Taylor BD: Mycoplasma genitalium: An emerging cause of pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2011:9598162011. View Article : Google Scholar : PubMed/NCBI | |
|
Baczynska A, Funch P, Fedder J, Knudsen HJ, Birkelund S and Christiansen G: Morphology of human Fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis-in vitro organ culture study. Hum Reprod. 22:968–979. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Crum CP, McKeon FD and Xian W: The oviduct and ovarian cancer: Causality, clinical implications, and ‘targeted prevention’. Clin Obstet Gynecol. 55:24–35. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
McGowin CL, Annan RS, Quayle AJ, Greene SJ, Ma L, Mancuso MM, Adegboye D and Martin DH: Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun. 80:3842–3849. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
McGowin CL, Radtke AL, Abraham K, Martin DH and Herbst-Kralovetz M: Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model. J Infect Dis. 207:1857–1868. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS and Markowitz LE: Prevalence of HPV infection among females in the United States. JAMA. 297:813–819. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Wu RF, Li CQ, Wei LH, Xu AD, et al: Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population-based studies. Int J Cancer. 131:2929–2938. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hong H, He TF, Ni HX, Zhang S and Xu GZ: Prevalence and genotype distribution of HPV infection among women in Ningbo, China. Int J Gynaecol Obstet. 131:96–99. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Q, Xie LX, Qing ZR, Li LJ, Luo ZY, Lin M, Zhang SM, Chen WZ, Lin BZ, Lin QL, et al: Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China. PLoS One. 7:e321492012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YY, Li L, Wei S, Peng J, Yuan SX, Xie JS and Liu ZH: Human papillomavirus (HPV) infection in women participating in cervical cancer screening from to 2010 in Shenzhen city, South China. Asian Pac J Cancer Prev. 14:7483–7487. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sui S, Jiao Z, Niyazi MSS, Lu P and Qiao YL: Genotype distribution and behavioral risk factor analysis of human papillomavirus infection in Uyghur women. Asian Pac J Cancer Prev. 14:5861–5865. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, : Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M and Larsson E: The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun. 4:25132013. View Article : Google Scholar : PubMed/NCBI | |
|
Rosa MI, Silva GD, de Azedo Simões PW, Souza MV, Panatto AP, Simon CS, Madeira K and Medeiros LR: The prevalence of human papillomavirus in ovarian cancer: A systematic review. Int J Gynecol Cancer. 23:437–441. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Shabanah OA, Hafez MM, Hassan ZK, Sayed-Ahmed MM, Abozeed WN, Al-Rejaie SS and Alsheikh AA: Human papillomavirus genotyping and integration in ovarian cancer Saudi patients. Virol J. 10:3432013. View Article : Google Scholar : PubMed/NCBI | |
|
Bilyk OO, Pande NT, Pejovic T and Buchinska LG: The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer. Exp Oncol. 36:121–124. 2014.PubMed/NCBI | |
|
Bilyk OO, Pande NT and Buchynska LG: Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas. Exp Oncol. 33:150–156. 2011.PubMed/NCBI | |
|
Mahmood FM, Kadhim HS and Al Khuzaee LR Mousa: Detection of human papillomavirus-16 e6-oncoprotein in epithelial ovarian tumors samples of iraqi patients. Jundishapur J Microbiol. 7:e119452014.PubMed/NCBI | |
|
Ghittoni R, Accardi R, Chiocca S and Tommasino M: Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience. 9:5262015. View Article : Google Scholar : PubMed/NCBI | |
|
Münger K and Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res. 89:213–228. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Park JW, Nickel KP, Torres AD, Lee D, Lambert PF and Kimple RJ: Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage. Radiother Oncol. 113:337–344. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Honegger A, Schilling D, Bastian S, Sponagel J, Kuryshev V, Sültmann H, Scheffner M, Hoppe-Seyler K and Hoppe-Seyler F: Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog. 11:e10047122015. View Article : Google Scholar : PubMed/NCBI | |
|
Gregoire L, Rabah R, Schmelz EM, Munkarah A, Roberts PC and Lancaster WD: Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro. Clin Cancer Res. 7:4280–4287. 2001.PubMed/NCBI | |
|
Yu J, Solano FX Jr and Seethala RR: Bilateral cytomegalovirus (CMV) oophoritis mimicking widely metastatic carcinoma: A case report and review of the literature. Diagn Pathol. 2:502007. View Article : Google Scholar : PubMed/NCBI | |
|
Wick W and Platten M: CMV infection and glioma, a highly controversial concept struggling in the clinical arena. Neuro Oncol. 16:332–333. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Richardson AK, Currie MJ, Robinson BA, Morrin H, Phung Y, Pearson JF, Anderson TP, Potter JD and Walker LC: Cytomegalovirus and Epstein-Barr virus in breast cancer. PLoS One. 10:e01189892015. View Article : Google Scholar : PubMed/NCBI | |
|
Han CP, Tsao YP, Sun CA, Ng HT and Chen SL: Human papillomavirus, cytomegalovirus and herpes simplex virus infections for cervical cancer in Taiwan. Cancer Lett. 120:217–221. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI and Cobbs CS: Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 360:1557–1563. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Samanta M, Harkins L, Klemm K, Britt WJ and Cobbs CS: High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol. 170:998–1002. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Michaelis M, Baumgarten P, Mittelbronn M, Driever PH, Doerr HW and Cinatl J Jr: Oncomodulation by human cytomegalovirus: Novel clinical findings open new roads. Med Microbiol Immunol. 200:1–5. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Söderberg-Nauclér C and Johnsen JI: Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options. World J Exp Med. 5:1–10. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bentz GL and Yurochko AD: Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci USA. 105:pp. 5531–5536. 2008; View Article : Google Scholar : PubMed/NCBI | |
|
Bishop RK, Oseguera CA Valle and Spencer JV: Human cytomegalovirus interleukin-10 promotes proliferation and migration of MCF-7 breast cancer cells. Cancer Cell Microenviron. 2(pii): e6782015.PubMed/NCBI | |
|
Price RL, Song J, Bingmer K, Kim TH, Yi JY, Nowicki MO, Mo X, Hollon T, Murnan E, Alvarez-Breckenridge C, et al: Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res. 73:3441–3450. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Scrivo R, Vasile M, Bartosiewicz I and Valesini G: Inflammation as ‘common soil’ of the multifactorial diseases. Autoimmun Rev. 10:369–374. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Karin M, Lawrence T and Nizet V: Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer. Cell. 124:823–835. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Whiteside TL: The role of immune cells in the tumor microenvironment. Cancer Treat Res. 130:103–124. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Enzler T, Gillessen S, Manis JP, Ferguson D, Fleming J, Alt FW, Mihm M and Dranoff G: Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med. 197:1213–1219. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Macciò A and Madeddu C: Inflammation and ovarian cancer. Cytokine. 58:133–147. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, et al: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 10:942–949. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD; Georgia Chenevix-Trench; for AOCS; /ACS Group, ; Rossing MA, Cramer D, Pearce CL, et al: Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 23:1421–1427. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, et al: Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: A pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst. 106:djt4312014. View Article : Google Scholar : PubMed/NCBI | |
|
Hu T, Li LF, Shen J, Zhang L and Cho CH: Chronic inflammation and colorectal cancer: The role of vascular endothelial growth factor. Curr Pharm Des. 21:2960–2967. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ellis LM and Hicklin DJ: VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 8:579–591. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Noort AR, van Zoest KP, Weijers EM, Koolwijk P, Maracle CX, Novack DV, Siemerink MJ, Schlingemann RO, Tak PP and Tas SW: NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis. J Pathol. 234:375–385. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
De Spiegelaere W, Cornillie P, Casteleyn C, Burvenich C and Van den Broeck W: Detection of hypoxia inducible factors and angiogenic growth factors during foetal endochondral and intramembranous ossification. Anat Histol Embryol. 39:376–384. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Sun M, Wang L and Jiao B: HIFs, angiogenesis, and cancer. J Cell Biochem. 114:967–974. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sherer DM, Eliakim R and Abulafia O: The role of angiogenesis in the accumulation of peritoneal fluid in benign conditions and the development of malignant ascites in the female. Gynecol Obstet Invest. 50:217–224. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Li S, Chen R, Yu H and Lu X: The prognostic significance of anti-angiogenesis therapy in ovarian cancer: A meta-analysis. J Ovarian Res. 8:542015. View Article : Google Scholar : PubMed/NCBI | |
|
Jayson GC, Kohn EC, Kitchener HC and Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li G, He L, Zhang E, Shi J, Zhang Q, Le AD, Zhou K and Tang X: Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lungcancer cells. Cancer Lett. 311:160–170. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Matlaf LA, Harkins LE, Bezrookove V, Cobbs CS and Soroceanu L: Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One. 8:e681762013. View Article : Google Scholar : PubMed/NCBI | |
|
Barriere G, Fici P, Gallerani G, Fabbri F and Rigaud M: Epithelial mesenchymal transition: A double-edged sword. Clin Transl Med. 4:142015. View Article : Google Scholar : PubMed/NCBI | |
|
Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YL, Zhao XM, Shuai ZF, Li CY, Bai QY, Yu XW and Wen QT: Snail promotes epithelial-mesenchymal transition and invasiveness in human ovarian cancer cells. Int J Clin Exp Med. 8:7388–7393. 2015.PubMed/NCBI | |
|
Wu J, Liu Z, Shao C, Gong Y, Hernando E, Lee P, Narita M, Muller W, Liu J and Wei JJ: HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes. Cancer Res. 71:349–359. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, et al: EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer. 12:912012. View Article : Google Scholar : PubMed/NCBI | |
|
Cohen EN, Gao H, Anfossi S, Mego M, Reddy NG, Debeb B, Giordano A, Tin S, Wu Q, Garza RJ, et al: Inflammation mediated metastasis: Immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells. PLoS One. 10:e01327102015. View Article : Google Scholar : PubMed/NCBI | |
|
Choi YJ, Kim N, Chang H, Lee HS, Park SM, Park JH, Shin CM, Kim JM, Kim JS, Lee DH and Jung HC: Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells. Carcinogenesis. 36:553–563. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chandrakesan P, Roy B, Jakkula LU, Ahmed I, Ramamoorthy P, Tawifik O, Papineni R, Houchen C, Anant S and Umar S: Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis. Oncogene. 33:2639–2654. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Duan H, Qu L and Shou C: Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling. Cancer Lett. 354:447–454. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Tian WD, Xu X, Nie B, Lu J, Liu X, Zhang B, Dong Q, Sunwoo JB, Li G and Li XP: Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. Cancer. 120:363–372. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bose SK, Meyer K, Di Bisceglie AM, Ray RB and Ray R: Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes. J Virol. 86:13621–13628. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Li Y, Liu D and Liu J: LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling. Tumour Biol. 35:10429–10435. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao L, Yang R, Cheng L, Wang M, Jiang Y and Wang S: LPS-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells. J Surg Res. 171:819–825. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kondo Y, Higa-Nakamine S, Noguchi N, Maeda N, Toku S, Isohama Y, Sugahara K, Kukita I and Yamamoto H: Induction of epithelial-mesenchymal transition by flagellin in cultured lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 303:L1057–L1069. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Franchi L, Park JH, Shaw MH, Marina-Garcia N, Chen G, Kim YG and Núñez G: Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol. 10:1–38. 2008.PubMed/NCBI | |
|
Park GB, Kim D, Kim YS, Kim S, Lee HK, Yang JW and Hur DY: The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways. Invest Ophthalmol Vis Sci. 55:1770–1779. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M and Pagano JS: Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 67:1970–1978. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sides MD, Klingsberg RC, Shan B, Gordon KA, Nguyen HT, Lin Z, Takahashi T, Flemington EK and Lasky JA: The Epstein-Barr virus latent membrane protein 1 and transforming growth factor-β1 synergistically induce epithelial-mesenchymal transition in lung epithelial cells. Am J Respir Cell Mol Biol. 44:852–862. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Li T, Li D, Cheng L, Wu H, Gao Z, Liu Z, Jiang W, Gao YH, Tian F, Zhao L and Wang S: Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma. Ann Surg Oncol. 17:1937–1944. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bapat SA, Mali AM, Koppikar CB and Kurrey NK: Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 65:3025–3029. 2005.PubMed/NCBI | |
|
Garson K and Vanderhyden BC: Epithelial ovarian cancer stem cells: Underlying complexity of a simple paradigm. Reproduction. 149:R59–R70. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Korkaya H, Liu S and Wicha MS: Regulation of cancer stem cells by cytokine networks: Attacking cancer's inflammatory roots. Clin Cancer Res. 17:6125–6129. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Leizer AL, Alvero AB, Fu HH, Holmberg JC, Cheng YC, Silasi DA, Rutherford T and Mor G: Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells. Am J Reprod Immunol. 65:438–447. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chefetz I, Alvero AB, Holmberg JC, Lebowitz N, Craveiro V, Yang-Hartwich Y, Yin G, Squillace L, Soteras M Gurrea, Aldo P and Mor G: TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence. Cell Cycle. 12:511–521. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xiang T, Long H, He L, Han X, Lin K, Liang Z, Zhuo W, Xie R and Zhu B: Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer. Oncogene. 34:165–176. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Castells M, Milhas D, Gandy C, Thibault B, Rafii A, Delord JP and Couderc B: Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation. Cell Death Dis. 4:e8872013. View Article : Google Scholar : PubMed/NCBI | |
|
Farina A, Cirone M, York M, Lenna S, Padilla C, McLaughlin S, Faggioni A, Lafyatis R, Trojanowska M and Farina GA: Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma. J Invest Dermatol. 134:954–964. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
He Z, Gao Y, Deng Y, Li W, Chen Y, Xing S, Zhao X, Ding J and Wang X: Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway. PLoS One. 7:e359262012. View Article : Google Scholar : PubMed/NCBI | |
|
Erez N, Glanz S, Raz Y, Avivi C and Barshack I: Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors. Biochem Biophys Res Commun. 437:397–402. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, Zaid TM, Ghosh S, Birrer MJ and Mok SC: TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 73:5016–5028. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Dimanche-Boitrel MT, Vakaet L Jr, Pujuguet P, Chauffert B, Martin MS, Hammann A, Van Roy F, Mareel M and Martin F: In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: An enhancing role of tumor-associated myofibroblasts. Int J Cancer. 56:512–521. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Boire A, Covic L, Agarwal A, Jacques S, Sherifi S and Kuliopulos A: PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell. 120:303–313. 2005. View Article : Google Scholar : PubMed/NCBI |
